Bellevue Life Sciences Acquisition CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OSR Holdings, Inc. reported a significant increase in net loss for fiscal year 2025, driven by higher operating expenses and one-time merger-related costs, while advancing its biotech pipeline and expanding its medical device distribution business.
OSR Holdings, a global healthcare company, finalized its merger with Bellevue Life Sciences Acquisition Corp., but faces immediate financial challenges due to a canceled PIPE investment and existing debt.
Bellevue Life Sciences Acquisition Corp.'s 10-K filing details its financial status, ongoing efforts to secure a business combination, and strategic focus on the healthcare sector.